ID   CNTP2_HUMAN             Reviewed;        1331 AA.
AC   Q9UHC6; D3DWG2; Q14DG2; Q52LV1; Q5H9Q7; Q9UQ12;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   21-MAR-2012, entry version 114.
DE   RecName: Full=Contactin-associated protein-like 2;
DE   AltName: Full=Cell recognition molecule Caspr2;
DE   Flags: Precursor;
GN   Name=CNTNAP2; Synonyms=CASPR2, KIAA0868;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Brain;
RX   MEDLINE=20088303; PubMed=10624965; DOI=10.1016/S0896-6273(00)81049-1;
RA   Poliak S., Gollan L., Martinez R., Custer A., Einheber S.,
RA   Salzer J.L., Trimmer J.S., Shrager P., Peles E.;
RT   "Caspr2, a new member of the neurexin superfamily, is localized at the
RT   juxtaparanodes of myelinated axons and associates with K+ channels.";
RL   Neuron 24:1037-1047(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=21250995; PubMed=11352571; DOI=10.1006/geno.2001.6517;
RA   Nakabayashi K., Scherer S.W.;
RT   "The human contactin-associated protein-like 2 gene (CNTNAP2) spans
RT   over 2 Mb of DNA at chromosome 7q35.";
RL   Genomics 73:108-112(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=99156230; PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN CDFES.
RX   PubMed=16571880; DOI=10.1056/NEJMoa052773;
RA   Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S.,
RA   Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H.;
RT   "Recessive symptomatic focal epilepsy and mutant contactin-associated
RT   protein-like 2.";
RL   N. Engl. J. Med. 354:1370-1377(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1303 AND SER-1306, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   VARIANTS GLN-114; MET-218; MET-226; CYS-283; ASN-382; SER-407;
RP   ASP-418; LYS-680; GLN-699; CYS-716; SER-731; ASP-779; THR-869;
RP   HIS-906; ASN-1038; ALA-1102; GLY-1114; HIS-1119; HIS-1129; THR-1227;
RP   THR-1253 AND ILE-1278, CHROMOSOMAL REARRANGEMENT, AND ASSOCIATION WITH
RP   SUSCEPTIBILITY TO AUTISM.
RX   PubMed=18179895; DOI=10.1016/j.ajhg.2007.09.017;
RA   Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F.,
RA   Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G.,
RA   Stillman A.A., Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M.,
RA   Geschwind D.H., Biederer T., Gunel M., Lifton R.P., State M.W.;
RT   "Molecular cytogenetic analysis and resequencing of contactin
RT   associated protein-like 2 in autism spectrum disorders.";
RL   Am. J. Hum. Genet. 82:165-173(2008).
CC   -!- FUNCTION: May play a role in the formation of functional distinct
CC       domains critical for saltatory conduction of nerve impulses in
CC       myelinated nerve fibers. Seems to demarcate the juxtaparanodal
CC       region of the axo-glial junction.
CC   -!- SUBUNIT: Associates with KCNA2 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein (Potential).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UHC6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UHC6-2; Sequence=VSP_014976;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in nervous system.
CC   -!- DISEASE: Defects in CNTNAP2 are the cause of cortical dysplasia-
CC       focal epilepsy syndrome (CDFES) [MIM:610042]. Affected individuals
CC       manifest cortical dysplasia, focal epilepsy, relative
CC       macrocephaly, and diminished deep-tendon reflexes. Intractable
CC       focal seizures begin in early childhood, after which language
CC       regression, hyperactivity, impulsive and aggressive behavior, and
CC       mental retardation develop.
CC   -!- DISEASE: Genetic variations in CNTNAP2 influences susceptibility
CC       to autism type 15 (AUTS15) [MIM:612100]. Autism is a
CC       neurodevelopmental disorder characterized by disturbance in
CC       language, perception and socialization. The disorder is
CC       classically defined by a triad of limited or absent verbal
CC       communication, a lack of reciprocal social interaction or
CC       responsiveness, and restricted, stereotypical, and ritualized
CC       patterns of interests and behavior.
CC   -!- DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found
CC       in a patient with autism spectrum disorder. Paracentric inversion
CC       46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the
CC       genes AUTS2 and CNTNAP2.
CC   -!- SIMILARITY: Belongs to the neurexin family.
CC   -!- SIMILARITY: Contains 2 EGF-like domains.
CC   -!- SIMILARITY: Contains 1 F5/8 type C domain.
CC   -!- SIMILARITY: Contains 1 fibrinogen C-terminal domain.
CC   -!- SIMILARITY: Contains 4 laminin G-like domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74891.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF193613; AAF25199.1; -; mRNA.
DR   EMBL; AF319045; AAK34932.1; -; mRNA.
DR   EMBL; AF318292; AAK49902.1; -; Genomic_DNA.
DR   EMBL; AF318298; AAK49903.1; -; Genomic_DNA.
DR   EMBL; AB020675; BAA74891.1; ALT_INIT; mRNA.
DR   EMBL; CR933671; CAI45967.1; -; mRNA.
DR   EMBL; CH471146; EAW80084.1; -; Genomic_DNA.
DR   EMBL; BC093780; AAH93780.1; -; mRNA.
DR   EMBL; BC113373; AAI13374.1; -; mRNA.
DR   IPI; IPI00029343; -.
DR   IPI; IPI00646209; -.
DR   RefSeq; NP_054860.1; NM_014141.5.
DR   UniGene; Hs.655684; -.
DR   ProteinModelPortal; Q9UHC6; -.
DR   SMR; Q9UHC6; 33-182, 184-606, 798-1209.
DR   IntAct; Q9UHC6; 5.
DR   MINT; MINT-241211; -.
DR   STRING; Q9UHC6; -.
DR   PhosphoSite; Q9UHC6; -.
DR   DMDM; 17433089; -.
DR   PRIDE; Q9UHC6; -.
DR   Ensembl; ENST00000361727; ENSP00000354778; ENSG00000174469.
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   UCSC; uc003weu.1; human.
DR   UCSC; uc003wev.1; human.
DR   CTD; 26047; -.
DR   GeneCards; GC07P145863; -.
DR   H-InvDB; HIX0021741; -.
DR   HGNC; HGNC:13830; CNTNAP2.
DR   HPA; HPA002739; -.
DR   MIM; 604569; gene.
DR   MIM; 610042; phenotype.
DR   MIM; 612100; phenotype.
DR   neXtProt; NX_Q9UHC6; -.
DR   Orphanet; 163681; Cortical dysplasia - focal epilepsy syndrome.
DR   Orphanet; 221150; Pitt-Hopkins-like syndrome.
DR   eggNOG; NOG291100; -.
DR   GeneTree; ENSGT00560000076804; -.
DR   HOGENOM; HBG443585; -.
DR   HOVERGEN; HBG057718; -.
DR   InParanoid; Q9UHC6; -.
DR   KO; K07380; -.
DR   OMA; RAWTAPS; -.
DR   OrthoDB; EOG4RV2QH; -.
DR   PhylomeDB; Q9UHC6; -.
DR   NextBio; 47891; -.
DR   ArrayExpress; Q9UHC6; -.
DR   Bgee; Q9UHC6; -.
DR   CleanEx; HS_CNTNAP2; -.
DR   Genevestigator; Q9UHC6; -.
DR   GO; GO:0030673; C:axolemma; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; ISS:BHF-UCL.
DR   GO; GO:0005769; C:early endosome; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:BHF-UCL.
DR   GO; GO:0043204; C:perikaryon; ISS:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0045163; P:clustering of voltage-gated potassium channels; ISS:BHF-UCL.
DR   GO; GO:0021761; P:limbic system development; IEP:BHF-UCL.
DR   GO; GO:0008038; P:neuron recognition; NAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   GO; GO:0021756; P:striatum development; IEP:BHF-UCL.
DR   GO; GO:0071109; P:superior temporal gyrus development; IEP:BHF-UCL.
DR   GO; GO:0021794; P:thalamus development; IEP:BHF-UCL.
DR   GO; GO:0019226; P:transmission of nerve impulse; NAS:UniProtKB.
DR   GO; GO:0071625; P:vocalization behavior; IMP:BHF-UCL.
DR   InterPro; IPR000421; Coagulation_fac_5/8-C_type_dom.
DR   InterPro; IPR008985; ConA-like_lec_gl.
DR   InterPro; IPR013320; ConA-like_subgrp.
DR   InterPro; IPR000742; EG-like_dom.
DR   InterPro; IPR006210; EGF-like.
DR   InterPro; IPR006209; EGF-like_dom.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   Gene3D; G3DSA:2.60.120.200; ConA_like_subgrp; 5.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49899; ConA_like_lec_gl; 4.
DR   SUPFAM; SSF56496; Fibrinogen_a/b/g_C; 1.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   PROSITE; PS00022; EGF_1; FALSE_NEG.
DR   PROSITE; PS01186; EGF_2; FALSE_NEG.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; FALSE_NEG.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Chromosomal rearrangement;
KW   Complete proteome; Disulfide bond; EGF-like domain; Epilepsy;
KW   Glycoprotein; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     27       Potential.
FT   CHAIN        28   1331       Contactin-associated protein-like 2.
FT                                /FTId=PRO_0000019506.
FT   TOPO_DOM     28   1262       Extracellular (Potential).
FT   TRANSMEM   1263   1283       Helical; (Potential).
FT   TOPO_DOM   1284   1331       Cytoplasmic (Potential).
FT   DOMAIN       35    181       F5/8 type C.
FT   DOMAIN      216    368       Laminin G-like 1.
FT   DOMAIN      401    552       Laminin G-like 2.
FT   DOMAIN      554    591       EGF-like 1.
FT   DOMAIN      592    798       Fibrinogen C-terminal.
FT   DOMAIN      799    963       Laminin G-like 3.
FT   DOMAIN      963   1002       EGF-like 2.
FT   DOMAIN     1055   1214       Laminin G-like 4.
FT   MOD_RES    1303   1303       Phosphoserine.
FT   MOD_RES    1306   1306       Phosphoserine.
FT   CARBOHYD    289    289       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    346    346       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    363    363       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    379    379       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    436    436       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    506    506       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    507    507       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    546    546       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    630    630       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    735    735       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1116   1116       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1198   1198       N-linked (GlcNAc...) (Potential).
FT   DISULFID     35    181       By similarity.
FT   DISULFID    336    368       By similarity.
FT   DISULFID    520    552       By similarity.
FT   DISULFID    558    569       By similarity.
FT   DISULFID    563    578       By similarity.
FT   DISULFID    580    590       By similarity.
FT   DISULFID    936    963       By similarity.
FT   DISULFID    967    980       By similarity.
FT   DISULFID    974    989       By similarity.
FT   DISULFID    991   1001       By similarity.
FT   DISULFID   1178   1214       By similarity.
FT   VAR_SEQ       1   1223       Missing (in isoform 2).
FT                                /FTId=VSP_014976.
FT   VARIANT     114    114       R -> Q.
FT                                /FTId=VAR_046227.
FT   VARIANT     218    218       T -> M.
FT                                /FTId=VAR_046228.
FT   VARIANT     226    226       L -> M.
FT                                /FTId=VAR_046229.
FT   VARIANT     283    283       R -> C.
FT                                /FTId=VAR_046230.
FT   VARIANT     382    382       S -> N.
FT                                /FTId=VAR_046231.
FT   VARIANT     407    407       N -> S.
FT                                /FTId=VAR_046232.
FT   VARIANT     418    418       N -> D.
FT                                /FTId=VAR_046233.
FT   VARIANT     680    680       E -> K.
FT                                /FTId=VAR_046234.
FT   VARIANT     699    699       P -> Q.
FT                                /FTId=VAR_046235.
FT   VARIANT     716    716       Y -> C.
FT                                /FTId=VAR_046236.
FT   VARIANT     731    731       G -> S.
FT                                /FTId=VAR_046237.
FT   VARIANT     779    779       G -> D.
FT                                /FTId=VAR_046238.
FT   VARIANT     869    869       I -> T (associated with susceptibility to
FT                                autism).
FT                                /FTId=VAR_046239.
FT   VARIANT     906    906       R -> H.
FT                                /FTId=VAR_046240.
FT   VARIANT    1038   1038       D -> N.
FT                                /FTId=VAR_046241.
FT   VARIANT    1102   1102       V -> A.
FT                                /FTId=VAR_046242.
FT   VARIANT    1114   1114       S -> G.
FT                                /FTId=VAR_046243.
FT   VARIANT    1119   1119       R -> H.
FT                                /FTId=VAR_046244.
FT   VARIANT    1129   1129       D -> H.
FT                                /FTId=VAR_046245.
FT   VARIANT    1227   1227       A -> T.
FT                                /FTId=VAR_046246.
FT   VARIANT    1253   1253       I -> T.
FT                                /FTId=VAR_046247.
FT   VARIANT    1278   1278       T -> I.
FT                                /FTId=VAR_046248.
SQ   SEQUENCE   1331 AA;  148167 MW;  CFB2CB55BEFB99C2 CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYFFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
